Can this condition be a leukemoid reaction and how can it be detected using bone marrow aspiration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Distinguishing Leukemoid Reaction from Leukemia Using Bone Marrow Aspiration

Yes, this can be a leukemoid reaction, and bone marrow aspiration is essential to distinguish it from leukemia by demonstrating <20% blasts, absence of abnormal blast clustering (ALIP), normal maturation patterns, and lack of clonal cytogenetic abnormalities.

Key Diagnostic Approach

Bone Marrow Aspiration Findings That Distinguish Leukemoid Reaction from Leukemia

The critical distinction lies in blast percentage and cellular architecture:

  • Blast count threshold: Leukemia (specifically AML) requires ≥20% myeloblasts in bone marrow or peripheral blood, while leukemoid reaction shows <20% blasts with normal maturation 1, 2
  • Cell count requirement: Examine ≥500 nucleated cells on marrow smears containing spicules to ensure accurate blast quantification 2
  • Architectural patterns: In leukemia, blasts form abnormal aggregates or clusters (ALIP - abnormally localized immature myeloid precursors) in central marrow locations, defined as ≥3 aggregates (>5 myeloid precursors) or clusters (3-5 precursors), which are absent in leukemoid reactions 3

Essential Complementary Studies on Bone Marrow

Beyond morphology, these tests are mandatory to exclude leukemia:

  • Immunophenotyping by flow cytometry: Required to determine lineage involvement and confirm clonality; leukemia shows aberrant immunophenotypes (CD34+, CD117+, CD33+, myeloperoxidase+), while leukemoid reaction shows normal maturation patterns 1, 2
  • Cytogenetic analysis: Mandatory with minimum 20 metaphase cells analyzed; leukemia shows clonal abnormalities (t(8;21), inv(16), complex karyotype), while leukemoid reaction has normal karyotype 1, 2
  • CD34 immunohistochemistry: Useful for identifying blast clusters in tissue sections, though less reliable in hypocellular specimens 3

Morphological Features Favoring Leukemoid Reaction

Specific bone marrow findings that support reactive rather than neoplastic process:

  • Normal maturation sequence: Orderly progression from myeloblasts through promyelocytes, myelocytes, metamyelocytes to mature neutrophils without maturation arrest 4
  • Hypercellular marrow with granulocytic hyperplasia: Increased cellularity due to left-shifted granulopoiesis responding to cytokine stimulation, not clonal expansion 4, 5
  • Absence of dysplasia: No megaloblastic erythroid precursors, agranular granulocytes, or abnormal promyelocytes that characterize myelodysplastic features 3
  • Normal megakaryocyte distribution: Easily identifiable megakaryocytes in normal architectural distribution, unlike the disorganized pattern in MDS/AML 3

Clinical Context Integration

Peripheral Blood Findings Suggesting Leukemoid Reaction

These peripheral blood features help distinguish before bone marrow:

  • Leukocytosis >50,000 cells/μL: Traditional definition of leukemoid reaction when leukemia is excluded 4, 5
  • Toxic granulation and Döhle bodies: Reactive neutrophil changes absent in leukemia 4
  • Leukocyte alkaline phosphatase (LAP) score: Elevated in leukemoid reaction, low in CML (though this test is less commonly used now) 4

Underlying Causes to Investigate

Identifying the etiology confirms leukemoid reaction diagnosis:

  • Severe infections: Most common cause (59/105 cases in modern cohort), involving various microorganisms 5
  • Paraneoplastic syndrome: Second most common (17/105 cases), associated with solid tumors producing colony-stimulating factors 6, 7, 5
  • Other causes: Severe hemorrhage, acute hemolysis, intoxications, or corticosteroid therapy 4, 8

Critical Pitfalls to Avoid

Common diagnostic errors that lead to misclassification:

  • Insufficient cell count: Counting <500 cells leads to unreliable blast percentages; a 5% blast count with 100-cell differential has 95% confidence interval of 1.6-11.3%, versus 3.3-7.3% with 500-cell count 3
  • Hemodilution artifact: Flow cytometry blast percentages may be falsely low in fatty or fibrotic marrows due to specimen hemodilution; always correlate with morphology 3
  • Timing of aspiration: Performing bone marrow too early after growth factor therapy or transfusions can obscure true findings 1
  • Relying on peripheral blood alone: Bone marrow examination is essential for definitive diagnosis when leukemia is suspected 1, 2

Prognostic Implications

Leukemoid reaction carries significant mortality risk:

  • High mortality rate: Both infection-related and paraneoplastic leukemoid reactions have poor prognosis with high mortality 5
  • Risk factors for death: Lower hemoglobin, older age, and increased segmented neutrophil count are associated with increased mortality risk 5
  • Requires aggressive management: The underlying cause (severe infection or malignancy) demands immediate treatment 5

References

Guideline

Diagnosis of Leukemia in Primary Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Myeloid Leukemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Leukemoid reaction: A 21st-century cohort study.

International journal of laboratory hematology, 2020

Research

Paraneoplastic leukemoid reaction in solid tumors.

American journal of clinical oncology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.